2-181537230-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000885.6(ITGA4):​c.*1703G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.128 in 452,766 control chromosomes in the GnomAD database, including 4,653 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2037 hom., cov: 33)
Exomes 𝑓: 0.12 ( 2616 hom. )

Consequence

ITGA4
NM_000885.6 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.191
Variant links:
Genes affected
ITGA4 (HGNC:6140): (integrin subunit alpha 4) The gene encodes a member of the integrin alpha chain family of proteins. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain that function in cell surface adhesion and signaling. The encoded preproprotein is proteolytically processed to generate light and heavy chains that comprise the alpha 4 subunit. This subunit associates with a beta 1 or beta 7 subunit to form an integrin that may play a role in cell motility and migration. This integrin is a therapeutic target for the treatment of multiple sclerosis, Crohn's disease and inflammatory bowel disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
CERKL (HGNC:21699): (ceramide kinase like) This gene was initially identified as a locus (RP26) associated with an autosomal recessive form of retinitis pigmentosa (arRP) disease. This gene encodes a protein with ceramide kinase-like domains, however, the protein does not phosphorylate ceramide and its target substrate is currently unknown. This protein may be a negative regulator of apoptosis in photoreceptor cells. Mutations in this gene cause a form of retinitis pigmentosa characterized by autosomal recessive cone and rod dystrophy (arCRD). Alternative splicing of this gene results in multiple transcript variants encoding different isoforms and non-coding transcripts.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 2-181537230-G-T is Benign according to our data. Variant chr2-181537230-G-T is described in ClinVar as [Benign]. Clinvar id is 332985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.215 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ITGA4NM_000885.6 linkc.*1703G>T 3_prime_UTR_variant Exon 28 of 28 ENST00000397033.7 NP_000876.3 P13612-1
CERKLNM_201548.5 linkc.*954C>A 3_prime_UTR_variant Exon 13 of 13 ENST00000410087.8 NP_963842.1 Q49MI3-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ITGA4ENST00000397033.7 linkc.*1703G>T 3_prime_UTR_variant Exon 28 of 28 1 NM_000885.6 ENSP00000380227.2 P13612-1
CERKLENST00000410087.8 linkc.*954C>A 3_prime_UTR_variant Exon 13 of 13 1 NM_201548.5 ENSP00000386725.3 Q49MI3-2
CERKLENST00000684145.1 linkc.*954C>A 3_prime_UTR_variant Exon 12 of 12 ENSP00000508396.1 G0XYE7
CERKLENST00000409440.7 linkc.*954C>A downstream_gene_variant 2 ENSP00000387080.3 Q49MI3-9

Frequencies

GnomAD3 genomes
AF:
0.153
AC:
23145
AN:
151500
Hom.:
2037
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.218
Gnomad AMI
AF:
0.0482
Gnomad AMR
AF:
0.179
Gnomad ASJ
AF:
0.0704
Gnomad EAS
AF:
0.219
Gnomad SAS
AF:
0.0595
Gnomad FIN
AF:
0.192
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.110
Gnomad OTH
AF:
0.120
GnomAD2 exomes
AF:
0.134
AC:
17091
AN:
127790
AF XY:
0.123
show subpopulations
Gnomad AFR exome
AF:
0.233
Gnomad AMR exome
AF:
0.211
Gnomad ASJ exome
AF:
0.0705
Gnomad EAS exome
AF:
0.214
Gnomad FIN exome
AF:
0.209
Gnomad NFE exome
AF:
0.105
Gnomad OTH exome
AF:
0.123
GnomAD4 exome
AF:
0.116
AC:
34989
AN:
301148
Hom.:
2616
Cov.:
0
AF XY:
0.108
AC XY:
18508
AN XY:
171668
show subpopulations
African (AFR)
AF:
0.227
AC:
1941
AN:
8536
American (AMR)
AF:
0.211
AC:
5767
AN:
27268
Ashkenazi Jewish (ASJ)
AF:
0.0680
AC:
733
AN:
10784
East Asian (EAS)
AF:
0.219
AC:
2008
AN:
9164
South Asian (SAS)
AF:
0.0512
AC:
3054
AN:
59642
European-Finnish (FIN)
AF:
0.200
AC:
2463
AN:
12308
Middle Eastern (MID)
AF:
0.0548
AC:
63
AN:
1150
European-Non Finnish (NFE)
AF:
0.109
AC:
17250
AN:
158284
Other (OTH)
AF:
0.122
AC:
1710
AN:
14012
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
2096
4193
6289
8386
10482
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
166
332
498
664
830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.153
AC:
23170
AN:
151618
Hom.:
2037
Cov.:
33
AF XY:
0.157
AC XY:
11601
AN XY:
74120
show subpopulations
African (AFR)
AF:
0.218
AC:
9040
AN:
41380
American (AMR)
AF:
0.178
AC:
2715
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
0.0704
AC:
244
AN:
3468
East Asian (EAS)
AF:
0.218
AC:
1126
AN:
5160
South Asian (SAS)
AF:
0.0594
AC:
286
AN:
4816
European-Finnish (FIN)
AF:
0.192
AC:
2019
AN:
10536
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.110
AC:
7426
AN:
67726
Other (OTH)
AF:
0.122
AC:
257
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
987
1973
2960
3946
4933
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
248
496
744
992
1240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.129
Hom.:
2323
Bravo
AF:
0.155
Asia WGS
AF:
0.172
AC:
598
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Retinitis pigmentosa Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.86
DANN
Benign
0.45
PhyloP100
0.19
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11553356; hg19: chr2-182401957; API